G&E Healthcare Co Ltd
299480
Company Profile
Business description
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.
Contact
55, Chogwangsandandong-ro 6beon-gil
Gyeonggi-do
Hanam-si70955
KORT: +82 7078827485
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
10
Stocks News & Analysis
stocks
Steep downgrade for wide moat share
Regulatory pressures squeeze growth outlook for wide moat ASX share.
stocks
The strange effect of the 30% minimum capital gains tax
How the proposed CGT floor creates unexpected outcomes across different incomes.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,937.60 | 3.00 | -0.03% |
| CAC 40 | 8,436.24 | 43.63 | -0.51% |
| DAX 40 | 25,465.25 | 352.64 | -1.37% |
| Dow JONES (US) | 52,925.15 | 130.76 | -0.25% |
| FTSE 100 | 10,665.88 | 14.11 | 0.13% |
| HKSE | 24,092.04 | 595.15 | 2.53% |
| NASDAQ | 25,818.69 | 302.47 | -1.16% |
| Nikkei 225 | 68,176.70 | 80.26 | -0.12% |
| NZX 50 Index | 13,698.67 | 64.12 | -0.47% |
| S&P 500 | 7,503.85 | 33.58 | -0.45% |
| S&P/ASX 200 | 8,743.70 | 6.10 | 0.07% |
| SSE Composite Index | 4,011.05 | 20.82 | 0.52% |